Testing in US identifies high asymptomatic, presymptomatic Covid-19 cases

Testing among quarantined contacts of patients with Covid-19 in a correctional and detention facility in the US identified a high proportion of asymptomatic and presymptomatic cases

Drug testing
The government is now trying to understand how long it will take before the drug’s production can start in India
IANS Washington
2 min read Last Updated : Jul 28 2020 | 7:24 AM IST

Testing among quarantined contacts of patients with COVID-19 in a correctional and detention facility in the United States identified a high proportion of asymptomatic and presymptomatic cases, according a report of the Centers for Disease Control and Prevention (CDC).

The cases were not identified through symptom screening alone. Approximately one fourth of cases were found through serial testing during quarantine, according to the report, Xinhua news agency reported on Monday.

Correctional and detention facilities face unique challenges in detecting and mitigating transmission of SARS-CoV-2 infection, said the CDC.

On May 7, the CDC and the Louisiana Department of Health initiated an investigation to assess the prevalence of SARS-CoV-2 infection among incarcerated and detained persons residing in quarantined dormitories.

During May 7 to 21, among 98 incarcerated and detained persons who were quarantined because of exposure to the virus, 71 had laboratory-confirmed SARS-CoV-2 infection identified through serial testing.

Among those with positive test results, approximately one fourth had positive test results after one or two negative tests at previous time points in quarantine, and 45 percent did not report any symptoms at the time of testing, according to the CDC.

These findings suggest ongoing transmission among quarantined persons living in congregate settings, said the CDC.

Serial testing, particularly for close contacts of patients, is important for complete identification of cases and prompt public health response in congregate settings, said the CDC.

--IANS

rt/

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAsymptomaticHealth crisisUSA

First Published: Jun 30 2020 | 4:52 AM IST

Next Story